# Trial of Pazopanib in Patients With Solitary Fibrous Tumor and Extraskeletal Myxoid Chondrosarcoma

> **NCT02066285** · PHASE2 · COMPLETED · sponsor: **Grupo Espanol de Investigacion en Sarcomas** · enrollment: 96 (actual)

## Conditions studied

- Solitary Fibrous Tumor
- Extraskeletal Myxoid Chondrosarcoma

## Interventions

- **DRUG:** Pazopanib

## Key facts

- **NCT ID:** NCT02066285
- **Lead sponsor:** Grupo Espanol de Investigacion en Sarcomas
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2019-12
- **Final completion:** 2023-03-24
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2023-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02066285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02066285, "Trial of Pazopanib in Patients With Solitary Fibrous Tumor and Extraskeletal Myxoid Chondrosarcoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02066285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*